Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03932383 · ClinicalTrials.gov registry record · NA

3D Printer Modified CPAP Mask for Obstructive Sleep Apnea

A NA study of Obstructive Sleep Apnea, sponsored by Beth Israel Deaconess Medical Center.

Active
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT03932383 is a NA study of Obstructive Sleep Apnea that is active but no longer recruiting, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 20 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03932383, a NA study of Obstructive Sleep Apnea, is active but no longer recruiting, sponsored by Beth Israel Deaconess Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This is a prospective pilot to investigate the effect of 3D printer customized CPAP masks on the comfort of patients with obstructive sleep apnea.

Conditions Studied

Interventions

  • DEVICE Custom CPAP mask

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2018-04-04
Est. Completion 2021-07-01
Phase NA

What the Registry Record Tells You About NCT03932383

The ClinicalTrials.gov registry entry for NCT03932383 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (91% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Custom CPAP mask is the first listed.

NCT03932383 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03932383 about?

NCT03932383 is a clinical study titled "3D Printer Modified CPAP Mask for Obstructive Sleep Apnea". This is a prospective pilot to investigate the effect of 3D printer customized CPAP masks on the comfort of patients with obstructive sleep apnea.

What is the current status of trial NCT03932383?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2018-04-04. Estimated completion is 2021-07-01.

What conditions does trial NCT03932383 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea.

What interventions are being tested in trial NCT03932383?

The interventions under investigation include: Custom CPAP mask (DEVICE).

Who is sponsoring clinical trial NCT03932383?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03932383 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.